BetaThis search tool is in development. Find out more.
Digital Images

20 Rapid HIV-1/2 Antibody tests and sample developer solutio

Science Museum, London

Available online

view 20 Rapid HIV-1/2 Antibody tests and sample developer solutio

License

Attribution 4.0 International (CC BY 4.0)
You can use this work for any purpose, including commercial uses, without restriction under copyright law. You should also provide attribution to the original work, source and licence.
Creative Commons Attribution (CC BY 4.0) terms and conditions https://creativecommons.org/licenses/by/4.0
Credit: 20 Rapid HIV-1/2 Antibody tests and sample developer solutio. Credit: Science Museum, London. Attribution 4.0 International (CC BY 4.0)

Selected images from this work


About this work

Description

The OraQuick Advance Rapid HIV-1/2 Antibody tests are used for clinical HIV testing of blood and saliva samples. The OraQuick tests are in development and under FDA (United States Food and Drug Administration) trials as a self-administered HIV test. They are for patients to carry out under the supervision of a trained person and are for use in outreach programmes and mobile clinics. It is pain-free and requires neither a blood sample or laboratory testing. The patient sweeps between the gum and teeth with a swab, which is placed in the stand for 20-40 minutes. The swab then indicates a positive or negative result. Twenty antibody tests are shown with a sample developer solution vial and plastic stand. The kit was made by Orasure Technologies. HIV (Human Immunodeficiency Virus) is the virus that develops into AIDS. It can be transmitted via bodily fluids during unprotected sex, blood transfusions or sharing hypodermic needles. Symptoms may not appear for many years so it is possible to unknowingly infect other people during this time. The manufacturer claims that of those infected with HIV in the US, nearly a quarter are unaware of their condition. maker: Orasure Technologies Place made: United States

Subjects


Permanent link


We’re improving the information on this page. Find out more.